Fortis Healthcare Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Fortis Healthcare announces Q3 FY26 Financial Results".
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Healthcare reported strong Q3 FY26 results with consolidated revenue up 17.5% YoY at INR 2,265 Cr and operating EBITDA up 34.8% at INR 505 Cr, with margin expanding to 22.3% from 19.4% a year ago. Hospital business revenues grew 19.4% to INR 1,938 Cr with EBITDA margin improving to 21.7% (from 20.0%), driven by 14% growth in occupied beds and 4.5% higher ARPOB. Diagnostics (Agilus) revenue grew 8.3% to INR 371 Cr, but EBITDA margin jumped sharply to 23.1% from 14.4%, reflecting turnaround in the segment. Reported PAT fell 22.4% to INR 197 Cr due to a one-time exceptional loss of INR 55.2 Cr from new Labour Codes. The company also acquired People Tree Hospital in Bengaluru for INR 430 Cr and launched a new mental health facility 'Adayu' in Gurugram, while net debt rose to INR 2,547 Cr (Net Debt/EBITDA at 1.24x vs 0.41x) due to Agilus PE stake buyout and other acquisitions.
Positive for shareholders - strong revenue and EBITDA growth across both hospital and diagnostics segments, with margins expanding meaningfully. The acquisition-driven rise in leverage is a watchpoint, but remains manageable at 1.24x EBITDA. Short-term stock sentiment should be supported by the margin beat and growth visibility.